Response by Henriksen et al Regarding Article, "Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial".
Peter A HenriksenPeter S HallNinian N LangPublished in: Circulation (2024)
Keyphrases
- study protocol
- randomized controlled trial
- angiotensin converting enzyme
- healthcare
- palliative care
- angiotensin ii
- phase iii
- clinical trial
- left ventricular
- quality improvement
- double blind
- phase ii
- cross sectional
- affordable care act
- heart failure
- stem cells
- systematic review
- binding protein
- cell therapy
- chronic pain
- smoking cessation
- placebo controlled